Boyer M - Search Results

1

Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study.

Boyer M, Şendur MAN, Rodríguez-Abreu D, Park K, Lee DH, Çiçin I, Yumuk PF, Orlandi FJ, Leal TA, Molinier O, Soparattanapaisarn N, Langleben A, Califano R, Medgyasszay B, Hsia TC, Otterson GA, Xu L, Piperdi B, Samkari A, Reck M; KEYNOTE-598 Investigators. Boyer M, et al. J Clin Oncol. 2021 Jul 20;39(21):2327-2338. doi: 10.1200/JCO.20.03579. Epub 2021 Jan 29. J Clin Oncol. 2021. PMID: 33513313 Clinical Trial.

2

Recent advances in managing non-small-cell lung cancer: 4. Chemotherapy of metastatic cancer.

Clarke SJ, Boyer MJ. Clarke SJ, et al. Among authors: boyer mj. Med J Aust. 1997 Jun 2;166(S1):S14-6. Med J Aust. 1997. PMID: 9201199

3

Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancer.

Boyer MJ, Zalcberg J, Olver IN, Millward MJ, Richardson G, McKeage MJ. Boyer MJ, et al. Ann Oncol. 1997 May;8(5):485-9. doi: 10.1023/a:1008291606695. Ann Oncol. 1997. PMID: 9233529 Free article. Clinical Trial.

4

New chemotherapeutic agents in the treatment of non-small cell lung cancer: the Australian experience.

Boyer MJ. Boyer MJ. Chest. 1998 Jan;113(1 Suppl):24S-27S. doi: 10.1378/chest.113.1_supplement.24s. Chest. 1998. PMID: 9438686 Review.

5

Non-surgical therapy for patients with advanced non-small cell lung cancer.

Clarke SJ, Boyer MJ. Clarke SJ, et al. Among authors: boyer mj. Respirology. 1998 Sep;3(3):175-82. doi: 10.1111/j.1440-1843.1998.tb00117.x. Respirology. 1998. PMID: 9767616 Review.

6

Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer.

Clarke SJ, Abratt R, Goedhals L, Boyer MJ, Millward MJ, Ackland SP. Clarke SJ, et al. Among authors: boyer mj. Ann Oncol. 2002 May;13(5):737-41. doi: 10.1093/annonc/mdf115. Ann Oncol. 2002. PMID: 12075742 Free article. Clinical Trial.

7

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.

Millward MJ, Boyer MJ, Lehnert M, Clarke S, Rischin D, Goh BC, Wong J, McNeil E, Bishop JF. Millward MJ, et al. Among authors: boyer mj. Ann Oncol. 2003 Mar;14(3):449-54. doi: 10.1093/annonc/mdg118. Ann Oncol. 2003. PMID: 12598352 Free article. Clinical Trial.

8

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P. Vogelzang NJ, et al. Among authors: boyer m. J Clin Oncol. 2003 Jul 15;21(14):2636-44. doi: 10.1200/JCO.2003.11.136. J Clin Oncol. 2003. PMID: 12860938 Corrected and republished. Clinical Trial.

9

Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer.

Viney RC, Boyer MJ, King MT, Kenny PM, Pollicino CA, McLean JM, McCaughan BC, Fulham MJ. Viney RC, et al. Among authors: boyer mj. J Clin Oncol. 2004 Jun 15;22(12):2357-62. doi: 10.1200/JCO.2004.04.126. J Clin Oncol. 2004. PMID: 15197196 Clinical Trial.

10

A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.

Clarke SJ, Boyer MJ, Millward M, Underhill C, Moylan E, Yip D, White S, Childs A, Beale P, Latz J, Suri A, Iglesias JL. Clarke SJ, et al. Among authors: boyer mj. Lung Cancer. 2005 Sep;49(3):401-12. doi: 10.1016/j.lungcan.2005.04.003. Lung Cancer. 2005. PMID: 15923057 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

907 results

Search Page